Madison Wogksch, | |
1492 S Silicon Way Ste A, St George, UT 84770-7156 | |
(435) 275-8911 | |
Not Available |
Full Name | Madison Wogksch |
---|---|
Gender | Female |
Speciality | Community Health Worker |
Location | 1492 S Silicon Way Ste A, St George, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1487000303 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Secondary |
172V00000X | Community Health Worker | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Madison Wogksch, 1492 S Silicon Way Ste A, St George, UT 84770-7156 Ph: () - | Madison Wogksch, 1492 S Silicon Way Ste A, St George, UT 84770-7156 Ph: (435) 275-8911 |
News Archive
PDS Biotechnology Corporation today announced that the company has been awarded a $1.28M phase 2 SBIR contract by the National Cancer Institute division of the US National Institutes of Health. The contract provides funding to complete studies required to file an Investigational New Drug Application (IND) with the FDA for the company's lead human papillomavirus (HPV)-cancer product late in 2010.
It is a common complaint of many mothers that their children refuse food. Now Australian scientists are looking for answers to this problem in order to reduce the increase in the number of malnourished children who need medical help because of their picky eating.
Researchers at the University of California, San Diego School of Medicine and the UC San Diego Moores Cancer Center have identified a new drug discovery approach enabling the destruction of the most highly proliferative tumors.
The discovery of a relationship between two cell enzymes and their role in keeping the cell's energy generating machinery working smoothly could provide a new target for development of therapies for Parkinson's disease (PD).
› Verified 3 days ago